Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, orthotic and prosthetic patient-care center operator Hanger Orthopedic Group
With that in mind, let's take a closer look at Hanger's business and see what CAPS investors are saying about the stock right now.
|Headquarters (Founded)||Austin, Texas (1861)|
|Market Cap||$593.5 million|
|Trailing-12-Month Revenue||$868.4 million|
CEO Dr. Thomas Kirk (since 2008)
CFO George McHenry, Jr. (since 2001)
|Return on Equity (Average, Past 3 Years)||10.1%|
|Cash/Debt||$19.5 million / $506.1 million|
US Physical Therapy
Sources: Capital IQ (a division of Standard & Poor's) and Motley Fool CAPS.
On CAPS, 94% of the 108 members who have rated Hanger believe the stock will outperform the S&P 500 going forward. These bulls include All-Star fooluser17, who is ranked in the top 10% of our community, and ThreeOfClubs.
Just last month, fooluser17 tapped Hanger as an almost-perfect opportunity: "Aging population, good product, good p/e. I wish they had a dividend."
In fact, Hanger currently sports a cheapish forward P/E of 9.2. That represents a discount to industry peers like HealthSouth (13.5), US Physical Therapy (11.2), and Fresenius Medical Care
CAPS member ThreeOfClubs elaborates on the Hanger bull case:
The stock has a great management team and delivers products which are going to be high in demand in the near future. [Hanger] stands to benefit directly from an aging population and an increase in Medicare/Medicaid spending thanks to their focus on products which assist patients in a period of rehabilitation.
What do you think about Hanger, or any other stock for that matter? If you want to retire rich, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future, and on Motley Fool CAPS, thousands of investors are working every day to find them. CAPS is 100% free, so get started!
Interested in another easy way to track Hanger? Add it to your watchlist.Fool contributor Brian Pacampara owns no position in any of the companies mentioned. Try any of our Foolish newsletter services free for 30 days.